BRCA1 and ovarian carcinoma: This pathway dominates among epithelial ovarian cancers and is further promoted in BRCA1- and BRCA2-mutated tumors, thus necessitating major research efforts to improve diagnosis, as early detection is of utmost importance for therapeutic success.